Page last updated: 2024-09-04

vatalanib and Atherosclerosis

vatalanib has been researched along with Atherosclerosis in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Brokopp, CE; Enseleit, F; Kraenkel, N; Kuschnerus, K; Lohmann, C; Lüscher, TF; Matter, CM; Michels, S; Ruschitzka, F; Siciliani, G; von Lukowicz, T; Winnik, S	1

Other Studies

1 other study(ies) available for vatalanib and Atherosclerosis

Article	Year
Systemic VEGF inhibition accelerates experimental atherosclerosis and disrupts endothelial homeostasis--implications for cardiovascular safety. International journal of cardiology, 2013, Oct-03, Volume: 168, Issue:3 Topics: Angiogenesis Inhibitors; Animals; Atherosclerosis; Endothelium, Vascular; Homeostasis; Male; Mice; Mice, Inbred C57BL; Phthalazines; Pyridines; Vascular Endothelial Growth Factor A	2013

Article

Year

Systemic VEGF inhibition accelerates experimental atherosclerosis and disrupts endothelial homeostasis--implications for cardiovascular safety.

International journal of cardiology, 2013, Oct-03, Volume: 168, Issue:3

Topics: Angiogenesis Inhibitors; Animals; Atherosclerosis; Endothelium, Vascular; Homeostasis; Male; Mice; Mice, Inbred C57BL; Phthalazines; Pyridines; Vascular Endothelial Growth Factor A

2013